Global Automated Insulin Delivery Device Market Research Report 2024

Publication ID:

PB505259644

Publication Date:

May 14, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The Automated Insulin Delivery Device is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Automated Insulin Delivery Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an Automated Insulin Delivery System is referred to as a "closed-loop" system, an "Artificial pancreas" system, or an "autonomous system for glycemic control."

An Automated Insulin Delivery System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
The global Automated Insulin Delivery Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Automated Insulin Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Insulin Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Automated Insulin Delivery Device include Medtronic, Dexcom, Abbott, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, Beta Bionics, Admetsys and Defymed, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Automated Insulin Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Insulin Delivery Device.
Report Scope
The Automated Insulin Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Insulin Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Insulin Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospital
Clinic
Medical Research Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Insulin Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Insulin Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Automated Insulin Delivery Device Market Overview
1.1 Product Overview and Scope of Automated Insulin Delivery Device
1.2 Automated Insulin Delivery Device Segment by Type
1.2.1 Global Automated Insulin Delivery Device Market Value Comparison by Type (2024-2030)
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Automated Insulin Delivery Device Segment by Application
1.3.1 Global Automated Insulin Delivery Device Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Research Center
1.4 Global Automated Insulin Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Automated Insulin Delivery Device Revenue 2019-2030
1.4.2 Global Automated Insulin Delivery Device Sales 2019-2030
1.4.3 Global Automated Insulin Delivery Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Insulin Delivery Device Market Competition by Manufacturers
2.1 Global Automated Insulin Delivery Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Insulin Delivery Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Insulin Delivery Device Average Price by Manufacturers (2019-2024)
2.4 Global Automated Insulin Delivery Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Insulin Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Insulin Delivery Device, Product Type & Application
2.7 Automated Insulin Delivery Device Market Competitive Situation and Trends
2.7.1 Automated Insulin Delivery Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Insulin Delivery Device Players Market Share by Revenue
2.7.3 Global Automated Insulin Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Insulin Delivery Device Retrospective Market Scenario by Region
3.1 Global Automated Insulin Delivery Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Insulin Delivery Device Global Automated Insulin Delivery Device Sales by Region: 2019-2030
3.2.1 Global Automated Insulin Delivery Device Sales by Region: 2019-2024
3.2.2 Global Automated Insulin Delivery Device Sales by Region: 2025-2030
3.3 Global Automated Insulin Delivery Device Global Automated Insulin Delivery Device Revenue by Region: 2019-2030
3.3.1 Global Automated Insulin Delivery Device Revenue by Region: 2019-2024
3.3.2 Global Automated Insulin Delivery Device Revenue by Region: 2025-2030
3.4 North America Automated Insulin Delivery Device Market Facts & Figures by Country
3.4.1 North America Automated Insulin Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Insulin Delivery Device Sales by Country (2019-2030)
3.4.3 North America Automated Insulin Delivery Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automated Insulin Delivery Device Market Facts & Figures by Country
3.5.1 Europe Automated Insulin Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Insulin Delivery Device Sales by Country (2019-2030)
3.5.3 Europe Automated Insulin Delivery Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Insulin Delivery Device Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Insulin Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Insulin Delivery Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Insulin Delivery Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Automated Insulin Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Automated Insulin Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Insulin Delivery Device Sales by Country (2019-2030)
3.7.3 Latin America Automated Insulin Delivery Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Insulin Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Insulin Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Insulin Delivery Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Insulin Delivery Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Insulin Delivery Device Sales by Type (2019-2030)
4.1.1 Global Automated Insulin Delivery Device Sales by Type (2019-2024)
4.1.2 Global Automated Insulin Delivery Device Sales by Type (2025-2030)
4.1.3 Global Automated Insulin Delivery Device Sales Market Share by Type (2019-2030)
4.2 Global Automated Insulin Delivery Device Revenue by Type (2019-2030)
4.2.1 Global Automated Insulin Delivery Device Revenue by Type (2019-2024)
4.2.2 Global Automated Insulin Delivery Device Revenue by Type (2025-2030)
4.2.3 Global Automated Insulin Delivery Device Revenue Market Share by Type (2019-2030)
4.3 Global Automated Insulin Delivery Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Insulin Delivery Device Sales by Application (2019-2030)
5.1.1 Global Automated Insulin Delivery Device Sales by Application (2019-2024)
5.1.2 Global Automated Insulin Delivery Device Sales by Application (2025-2030)
5.1.3 Global Automated Insulin Delivery Device Sales Market Share by Application (2019-2030)
5.2 Global Automated Insulin Delivery Device Revenue by Application (2019-2030)
5.2.1 Global Automated Insulin Delivery Device Revenue by Application (2019-2024)
5.2.2 Global Automated Insulin Delivery Device Revenue by Application (2025-2030)
5.2.3 Global Automated Insulin Delivery Device Revenue Market Share by Application (2019-2030)
5.3 Global Automated Insulin Delivery Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Automated Insulin Delivery Device Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Dexcom
6.2.1 Dexcom Corporation Information
6.2.2 Dexcom Description and Business Overview
6.2.3 Dexcom Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dexcom Automated Insulin Delivery Device Product Portfolio
6.2.5 Dexcom Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Automated Insulin Delivery Device Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Insulet
6.4.1 Insulet Corporation Information
6.4.2 Insulet Description and Business Overview
6.4.3 Insulet Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Insulet Automated Insulin Delivery Device Product Portfolio
6.4.5 Insulet Recent Developments/Updates
6.5 Tandem Diabetes Care
6.5.1 Tandem Diabetes Care Corporation Information
6.5.2 Tandem Diabetes Care Description and Business Overview
6.5.3 Tandem Diabetes Care Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Tandem Diabetes Care Automated Insulin Delivery Device Product Portfolio
6.5.5 Tandem Diabetes Care Recent Developments/Updates
6.6 Bigfoot Biomedical
6.6.1 Bigfoot Biomedical Corporation Information
6.6.2 Bigfoot Biomedical Description and Business Overview
6.6.3 Bigfoot Biomedical Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bigfoot Biomedical Automated Insulin Delivery Device Product Portfolio
6.6.5 Bigfoot Biomedical Recent Developments/Updates
6.7 Beta Bionics
6.6.1 Beta Bionics Corporation Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beta Bionics Automated Insulin Delivery Device Product Portfolio
6.7.5 Beta Bionics Recent Developments/Updates
6.8 Admetsys
6.8.1 Admetsys Corporation Information
6.8.2 Admetsys Description and Business Overview
6.8.3 Admetsys Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Admetsys Automated Insulin Delivery Device Product Portfolio
6.8.5 Admetsys Recent Developments/Updates
6.9 Defymed
6.9.1 Defymed Corporation Information
6.9.2 Defymed Description and Business Overview
6.9.3 Defymed Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Defymed Automated Insulin Delivery Device Product Portfolio
6.9.5 Defymed Recent Developments/Updates
6.10 Micro Tech Medical
6.10.1 Micro Tech Medical Corporation Information
6.10.2 Micro Tech Medical Description and Business Overview
6.10.3 Micro Tech Medical Automated Insulin Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Micro Tech Medical Automated Insulin Delivery Device Product Portfolio
6.10.5 Micro Tech Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Insulin Delivery Device Industry Chain Analysis
7.2 Automated Insulin Delivery Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Insulin Delivery Device Production Mode & Process
7.4 Automated Insulin Delivery Device Sales and Marketing
7.4.1 Automated Insulin Delivery Device Sales Channels
7.4.2 Automated Insulin Delivery Device Distributors
7.5 Automated Insulin Delivery Device Customers
8 Automated Insulin Delivery Device Market Dynamics
8.1 Automated Insulin Delivery Device Industry Trends
8.2 Automated Insulin Delivery Device Market Drivers
8.3 Automated Insulin Delivery Device Market Challenges
8.4 Automated Insulin Delivery Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂